HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K

Documenti analoghi

• The Association of Heterozygous p.R4810K of RNF213 and Long-Term Unfavorable Outcomes after Encephaloduroarteriosynangiosis in Chinese Pediatric Patients with Moyamoya Disease
  di: Qingbao Guo, et al.
  Pubblicazione: (2024)
• Cerebrovascular imaging and neurocognitive outcomes in children with moyamoya
  di: Lauren Harris, et al.
  Pubblicazione: (2025)
• Identifying neurocognitive impairment risk in children with moyamoya: The role of routine neuroimaging
  di: Lisa R. Sun
  Pubblicazione: (2025)
• Diagnostic and Prognostic Utility of Plasma p‐tau217 for Alzheimer's Disease in Chinese Elderly: Insights From the SILCODE Study With a Derived Threshold
  di: Ruixian Li, et al.
  Pubblicazione: (2026)
• Real‐World Experience of Sustained‐Release Fampridine in Chinese Patients With Multiple Sclerosis: A Case Series on Walking Impairment and Fatigue
  di: Han Wang, et al.
  Pubblicazione: (2025)